514 related articles for article (PubMed ID: 11786970)
1. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Fernández J; Navasa M; Gómez J; Colmenero J; Vila J; Arroyo V; Rodés J
Hepatology; 2002 Jan; 35(1):140-8. PubMed ID: 11786970
[TBL] [Abstract][Full Text] [Related]
2. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
[TBL] [Abstract][Full Text] [Related]
3. Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis.
Alvarez RF; Mattos AA; Corrêa EB; Cotrim HP; Nascimento TV
Arq Gastroenterol; 2005; 42(4):256-62. PubMed ID: 16444382
[TBL] [Abstract][Full Text] [Related]
4. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes.
Llovet JM; Rodríguez-Iglesias P; Moitinho E; Planas R; Bataller R; Navasa M; Menacho M; Pardo A; Castells A; Cabré E; Arroyo V; Gassull MA; Rodés J
J Hepatol; 1997 Jan; 26(1):88-95. PubMed ID: 9148028
[TBL] [Abstract][Full Text] [Related]
6. Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences.
Aparicio JR; Such J; Pascual S; Arroyo A; Plazas J; Girona E; Gutiérrez A; de Vera F; Palazón JM; Carnicer F; Pérez-Mateo M
J Hepatol; 1999 Aug; 31(2):277-83. PubMed ID: 10453941
[TBL] [Abstract][Full Text] [Related]
7. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats.
Guarner C; Runyon BA; Heck M; Young S; Sheikh MY
Dig Dis Sci; 1999 Oct; 44(10):1957-62. PubMed ID: 10548343
[TBL] [Abstract][Full Text] [Related]
9. [Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination].
Aparicio JR; Such J; Gutiérrez A; Pérez-Mateo M; Plaza J; Arroyo A
Med Clin (Barc); 1999 Sep; 113(7):241-5. PubMed ID: 10544377
[TBL] [Abstract][Full Text] [Related]
10. Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis.
Alexopoulou A; Papadopoulos N; Eliopoulos DG; Alexaki A; Tsiriga A; Toutouza M; Pectasides D
Liver Int; 2013 Aug; 33(7):975-81. PubMed ID: 23522099
[TBL] [Abstract][Full Text] [Related]
11. Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections.
Marciano S; Gutierrez-Acevedo MN; Barbero S; Del C Notari L; Agozino M; Fernandez JL; Anders MM; Grigera N; Antinucci F; Orozco Ganem OF; Murga MD; Perez D; Palazzo A; Martinez Rejtman L; Duarte IG; Vorobioff J; Trevizan V; Bulaty S; Bessone F; Valverde M; Elizondo M; Bosia JD; Borzi SM; Stieben TE; Masola A; Ferretti SE; Arufe D; Demirdjian E; Raffa MP; Peralta M; Fainboim HA; Vazquez CE; Ruiz P; Martínez JE; Heffner LA; Odzak A; Dirchwolf M; Smud A; Mendizabal M; Bellizzi C; Martinez A; Tomatis J; Bruno A; Ramos A; Pages J; Tevez S; Gadano AC; Giunta DH
Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):481-491. PubMed ID: 36820931
[TBL] [Abstract][Full Text] [Related]
12. [Bacterial infections in liver cirrhosis].
Papp M; Farkas A; Udvardy M; Tornai I
Orv Hetil; 2007 Mar; 148(9):387-95. PubMed ID: 17344166
[TBL] [Abstract][Full Text] [Related]
13. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial.
Grangé JD; Roulot D; Pelletier G; Pariente EA; Denis J; Ink O; Blanc P; Richardet JP; Vinel JP; Delisle F; Fischer D; Flahault A; Amiot X
J Hepatol; 1998 Sep; 29(3):430-6. PubMed ID: 9764990
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis.
Campillo B; Dupeyron C; Richardet JP
Epidemiol Infect; 2001 Dec; 127(3):443-50. PubMed ID: 11811877
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients.
Lontos S; Shelton E; Angus PW; Vaughan R; Roberts SK; Gordon A; Gow PJ
J Dig Dis; 2014 May; 15(5):260-7. PubMed ID: 24612987
[TBL] [Abstract][Full Text] [Related]
16. Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis.
Lontos S; Gow PJ; Vaughan RB; Angus PW
J Gastroenterol Hepatol; 2008 Feb; 23(2):252-5. PubMed ID: 17559367
[TBL] [Abstract][Full Text] [Related]
17. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
Elfert A; Abo Ali L; Soliman S; Ibrahim S; Abd-Elsalam S
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1450-1454. PubMed ID: 27512927
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous bacterial peritonitis caused by quinolone-resistant Escherichia coli: could steroid therapy play a role?
Cereto F; Genescà J; Smithson A; González A; Moreno G; del Valle Ortiz O; Esteban R; Guardia J
Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):81-3. PubMed ID: 11782580
[TBL] [Abstract][Full Text] [Related]
19. [Spontaneous infection of ascitic fluid due to Salmonella typhimurium in a cirrhotic patient undergoing selective intestinal decontamination with norfloxacin].
Lecleire S; Di Fiore F; Hervé S; Goria O; Savoye G; Colin R; Lerebours E
Presse Med; 2003 Mar; 32(12):550-2. PubMed ID: 12714922
[TBL] [Abstract][Full Text] [Related]
20. Role of immunosuppression in the development of quinolone-resistant Escherichia coli spontaneous bacterial peritonitis and in the mortality of E. coli spontaneous bacterial peritonitis.
Cereto F; Molina I; González A; Del Valle O; Esteban R; Guardia J; Genescà J
Aliment Pharmacol Ther; 2003 Mar; 17(5):695-701. PubMed ID: 12641519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
